Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,724 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 301-325 of 1,000 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
12 Apr 2023
Reporting date
10 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-26727

ARS

Filing date
11 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-26727

DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

Filing date
11 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-26727

DEFINITIVE PROXY STATEMENT

Filing date
11 Apr 2023
Reporting date
Not listed
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2023
Reporting date
06 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
10 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
06 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2023
Reporting date
03 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
03 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
30 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
13 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
10 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .